A model of state-level prescription drug expenditures in the USA

Chutima Suraratdecha

Applied Economics Letters, 1996, vol. 3, issue 5, 289-292

Abstract: Research is scanty on pharmaceutical care expenditures of developed nations. This paper models the determinants of state-level prescription drug expenditures for the USA, based on pooled data for 1980, 1982, 1984, 1988 and 1990. The GLS regression results indicate that older adults age 65 or more, Medicaid recipients and realincome are strongly significant determinants. With the growing proportion of the elderly and the increasing poverty rates among Medicare and Medicaid recipients, pharmaceutical care reform proposals need to focus on preventive care, rather than expensive treatments.

Date: 1996
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.informaworld.com/openurl?genre=article& ... 40C6AD35DC6213A474B5 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:taf:apeclt:v:3:y:1996:i:5:p:289-292

Ordering information: This journal article can be ordered from
http://www.tandfonline.com/pricing/journal/RAEL20

DOI: 10.1080/135048596356375

Access Statistics for this article

Applied Economics Letters is currently edited by Anita Phillips

More articles in Applied Economics Letters from Taylor & Francis Journals
Bibliographic data for series maintained by Chris Longhurst ().